When should we consider contralateral prophylactic mastectomy in BRCA1/BRCA2 negative familial breast cancer patients? A study of histopathological patterns

Authors :: Fatima Aloraifi
Nuala Cody
Adrian P. Bracken
Trudi McDevitt
Rosemarie Kelly
James Geraghty
Cliona de Baroid
Andrew Green
Marie Meany
Source :: International Journal of Surgery. 10(8)
Publication Year :: 2012
Publisher :: Elsevier BV, 2012.

Subjects :: Oncology
medicine.medical_specialty
Contralateral Prophylactic Mastectomy
business.industry
Internal medicine
medicine
Surgery
General Medicine
Familial breast cancer
business
Brca1 brca2

Full Text Access

Tools